Skip to main content
. 2019 Oct 9;68(11):1733–1745. doi: 10.1007/s00262-019-02407-8

Table 1.

Univariate and multivariate analyses

Univariate DFS OS
p Hazard ratio 95.0% CI for exp (B) (range) p Hazard ratio 95.0% CI for exp (B) (range)
Molecular subtypes 0.001 1.555 1.197–2.019 0.008 1.650 1.130–2.409
Early advanced stage 0.001 4.332 1.837–10.212 0.006 17.564 2.293–134.540
T status 0.000 2.988 1.771–5.038 0.000 4.041 2.003–8.153
N status 0.000 2.168 1.467–3.205 0.000 3.229 1.844–5.654
Grade 0.188 1.559 0.805–3.019 0.036 3.317 1.083–10.160
Hormone receptors 0.003 0.323 0.152–0.689 0.010 0.249 0.086–0.719
HER-2/neu 0.591 1.247 0.564–2.758 0.539 0.670 0.187–2.403
Reinforced signatures 0.001 3.773 1.675–8.496 0.004 9.206 2.039–41.567
Multivariate DFS OS
p Hazard ratio 95.0% CI for exp (B) (range) p Hazard ratio 95.0% CI for exp (B) (range)
2. Model before stepwise selection
 Molecular subtypes 0.022 2.092 1.115–3.924 0.196 2.038 0.692–5.998
 Early–advanced stage 0.415 1.984 0.382–10.299 0.033 20.878 1.280–340.628
 T status 0.049 2.475 1.004–6.101 0.662 1.331 0.369–4.802
 N status 0.654 1.162 0.602–2.44 0.743 1.152 0.495–2.78
 Grade 0.387 0.693 0.302–1.591 0.706 1.378 0.261–7.276
 Hormone receptors 0.562 1.684 0.290–9.789 0.815 0.698 0.035–14.106
 HER-2/neu 0.756 0.847 0.298–2.407 0.016 0.140 0.028–0.690
 Reinforced signatures 0.009 3.450 1.366–8.708 0.014 11.026 1.631–74.533
2. Model after stepwise selection
 Molecular subtypes 0.000 1.685 1.268–2.241 0.000 2.432 1.528–3.871
 Early–advanced stage 0.002 37.148 3.808–362.371
 T status 0.000 3.522 1.774–6.993
 HER-2/neu 0.012 0.158 0.037–0.666
 Reinforced signature 0.009 2.981 1.307–6.802 0.003 12.583 2.362–67.024

All categorical covariates were transformed into numeric codes as follows: early–advanced stage (I–IIA; 1, IIB, IIIA, III3; 2), T status (T1; 1, T2; 2, T3; 3), N stage (N0; 0, N1; 1, N2; 2, N3; 3), grade (G1; 1, G2; 2, G3; 3), hormone receptors (neg; 0, pos; 1), HER-2/neu (neg; 0, pos; 1), reinforced signatures (RFCIS; 1, R UCIS; 2), molecular subtypes (Lum A; 1, Lum B; 2; luminal B/Her2 +, 3, HER2 +, 4 TNBC, 5)

CI confidence interval, HR hazard ratio